compounded glp-1 vs name brand Compounding: When Innovation May Mean Liability Compound versions of GLP-1 drugs

Organic rice hull

Big pharma is currently facing a potential bubble effect due to the surging demand for weight loss and diabetes drugs, as revealed in a report by Deloitte released on Monday

Learn FDA-approved guidelines for safely resuming Mounjaro or Zepbound after missing a dose, plus strategies to prevent treatment interruptions.

Forecasting models often overestimate ROI: Many commercial forecasts fail to account for patient leakage, especially in obesity indications, leading to inflated expectations and missed market realities

However, DPP-4 inhibitors have not reduced the risk of major adverse cardiovascular events, possibly because potentiation of SDF-1 enhances plaque growth and instability, activates deleterious neurohormonal mechanisms, and promotes cardiac inflammation and fibrosis